Literature DB >> 21215494

[Renal function in patients with metabolic syndrome attending primary care].

José Abellán Alemán, Miguel Ángel Prieto Díaz, Mariano Leal Hernández, Soledad García de Vinuesa, José Luño Fernández.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21215494      PMCID： PMC7024935          DOI： 10.1016/j.aprim.2010.05.018

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  5 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  The role of the kidney in cardiovascular medicine.

Authors:  Eberhard Ritz
Journal:  Eur J Intern Med       Date:  2005-09       Impact factor: 4.487

3.  [Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome].

Authors:  José A Gimeno-Orna; Edmundo Molinero-Herguedas; Luis M Lou-Arnal; Beatriz Boned-Juliani; Tomás Labrador-Fuster; Miguel Guiu-Campos
Journal:  Rev Esp Cardiol       Date:  2007-11       Impact factor: 4.753

4.  [Prevalence of metabolic syndrome in the province of Albacete (Spain)].

Authors:  J M Calbo Mayo; I Terrancle de Juan; P Fernández Jiménez; M J Rodríguez Martín; V Martínez Díaz; Y Santisteban López; A Navarro Martínez; L Sáez Méndez; J Gómez Garrido; J Moreno Salcedo; J Vera Hernández; O Fuster Lluch; J L Beato; J M Bleda; J Solera Santos
Journal:  Rev Clin Esp       Date:  2007-02       Impact factor: 1.556

5.  [Prevalence of the metabolic syndrome in Spanish patients with established cardiovascular disease: CLYDIA study].

Authors:  José Luis Palma Gámiz; Ignacio Conget Donlo; Vicente Bertomeu González; Juan F Ascaso Gimilio; José R González Juanatey; Eduardo Alegría Ezquerra; Pedro Conthe Gutiérrez; Hermenegildo de la Calle Blasco; Manuel Serrano Ríos
Journal:  Med Clin (Barc)       Date:  2007-03-24       Impact factor: 1.725
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.